Valeant Pharmaceuticals International Inc (NYSE:VRX)

17.54
Delayed Data
As of 4:01pm ET
 +0.07 / +0.40%
Today’s Change
8.50
Today|||52-Week Range
24.43
-15.59%
Year-to-Date

Today’s Trading

Previous close17.47
Today’s open17.33
Day’s range16.98 - 17.69
Volume4,864,229
Average volume (3 months)12,578,905
Market cap$5.4B
Data as of 4:01pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-21.33%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-9.82%
P/E ratio2.6
Price/Sales0.84
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-1.05-1.13%
ACADACADIA Pharmaceutica...-4.27-21.93%
TAROTaro Pharmaceutical ...-0.25-0.25%
----
Data as of 4:01pm ET, 04/25/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$8.7B
Annual profit (last year)$2.4B
Net profit margin27.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive Vice President
Paul S. Herendeen
Corporate headquarters
Laval, Qubec

Forecasts